AVEO PHARMACEUTICALS INC - COM (AVEO)

Historical Holders from Q1 2014 to Q3 2021

Type / Class
Equity / COM
Symbol
AVEO
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2021 Q3 0 $0 -$30,000 0
2021 Q2 1,939 $30,000 $15.47 1
2021 Q1 1,939 $28,000 $14.44 1
2020 Q4 1,939 $25,000 -$443,000 $12.89 1
2020 Q3 76,491 $462,000 +$51,364 $7.87 2
2020 Q2 67,847 $358,000 -$141,657 $7.47 2
2020 Q1 67,197 $254,000 -$28,084,593 $6.45 2
2019 Q4 42,404,682 $26,504,027 -$677,883 $0.6239 55
2019 Q3 42,798,755 $36,170,822 -$3,555,594 $0.8444 58
2019 Q2 47,488,698 $31,923,086 +$1,360,893 $0.6732 68
2019 Q1 45,474,647 $37,290,753 -$7,972,602 $0.8201 73
2018 Q4 49,644,694 $79,438,613 -$9,757,762 $1.60 92
2018 Q3 50,058,057 $165,780,373 -$25,517,908 $3.31 95
2018 Q2 60,147,956 $135,882,361 -$3,533,053 $2.26 85
2018 Q1 59,795,578 $173,406,137 -$3,570,322 $2.90 83
2017 Q4 61,342,763 $171,307,634 +$150,525 $2.79 83
2017 Q3 59,708,372 $218,044,927 -$7,926,389 $3.65 55
2017 Q2 63,600,286 $141,258,000 +$26,684,563 $2.22 46
2017 Q1 56,232,990 $33,175,472 +$16,881,985 $0.5900 41
2016 Q4 29,624,594 $15,994,432 +$396,244 $0.5400 35
2016 Q3 28,859,272 $25,682,712 -$778,265 $0.8900 38
2016 Q2 29,653,660 $28,487,769 +$15,210,581 $0.9611 41
2016 Q1 13,836,875 $12,727,736 -$144,703 $0.9197 32
2015 Q4 13,928,038 $17,553,008 -$1,279,290 $1.26 41
2015 Q3 15,570,603 $18,840,968 -$2,204,239 $1.21 46
2015 Q2 17,024,013 $29,619,336 +$3,293,221 $1.74 49
2015 Q1 15,251,148 $22,106,288 +$1,518,178 $1.45 48
2014 Q4 14,978,140 $12,625,253 -$4,881,039 $0.8400 49
2014 Q3 19,254,345 $21,371,768 -$6,981,364 $1.11 50
2014 Q2 23,078,445 $42,233,869 -$7,510,618 $1.83 59
2014 Q1 27,577,625 $41,247,854 -$9,221,610 $1.50 64